<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>51选刊 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-07T01:21:31+08:00</updated>
  <subtitle>如何选择SCI期刊，也是一门技巧。这里我们帮助大家选择拟投稿的SCI期刊！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>这本国产SCI期刊，院士主编，免版面费，影响因子已超10分</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/dGNJYefqWLO6BDGyOeVDAw</id>
    <link href="https://mp.weixin.qq.com/s/dGNJYefqWLO6BDGyOeVDAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本老牌SCI，发文量稳定，审稿快，对国人友好，今年影响因子9分+</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/6k_mzq3QRQb-PqvCzyWhIw</id>
    <link href="https://mp.weixin.qq.com/s/6k_mzq3QRQb-PqvCzyWhIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本年发文超6200篇的SCI，去年今年都是4分+，一个月即接受</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/Eeduea61QufTkR7yPwGTJA</id>
    <link href="https://mp.weixin.qq.com/s/Eeduea61QufTkR7yPwGTJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今年第1个IF果然达6分，明年或仍超6分 | 这本Nature旗下英文刊去年刚被SCI收录</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/uFGcN07cL3CBV44Pq6L4qQ</id>
    <link href="https://mp.weixin.qq.com/s/uFGcN07cL3CBV44Pq6L4qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本多年来，一直4分左右的SCI，接受需要3个月，中科院2区</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/y8QQ2cIg7BZ31pym2jJ_Cg</id>
    <link href="https://mp.weixin.qq.com/s/y8QQ2cIg7BZ31pym2jJ_Cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本国产SCI，今年喜获首个影响因子，接近5分</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/VViKEqkxbBQ6OZEWoFeseg</id>
    <link href="https://mp.weixin.qq.com/s/VViKEqkxbBQ6OZEWoFeseg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本 SCI 速度超快，一个月就可接收，国人发文少，今年首个IF接近5分</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/1ejp-kRHJrLYm0yWdyj5Ig</id>
    <link href="https://mp.weixin.qq.com/s/1ejp-kRHJrLYm0yWdyj5Ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>SCI期刊征稿(IF 3.693)：两三个月接受，截稿时间2021年3月10日</title>
    <updated>2020-11-06T23:55:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/lEzWrOQwGly2Tk3WeBCzKw</id>
    <link href="https://mp.weixin.qq.com/s/lEzWrOQwGly2Tk3WeBCzKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell旗下这本新入选SCI子刊，今年首个IF近30分，明年第二个或近40分</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/6wufjnvmqoyBMmjGRvU_ag</id>
    <link href="https://mp.weixin.qq.com/s/6wufjnvmqoyBMmjGRvU_ag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这个省规定，单项到位经费超50万元的横向项目，可与国家和省级项目同等对待</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/LPIH_NYGjwycwLnLZJwryg</id>
    <link href="https://mp.weixin.qq.com/s/LPIH_NYGjwycwLnLZJwryg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本国产SCI期刊，入选卓越计划，一审1个月，今年影响因子突破5分，位于Q1区</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/5e32eB9E4PyucmhxoCbCmQ</id>
    <link href="https://mp.weixin.qq.com/s/5e32eB9E4PyucmhxoCbCmQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>本周六免费直播 | 如何围绕一个idea，做纵向持续的临床科研？授课老师SCI论文40多篇，谷歌总他引&gt;500</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/TJwT56jketvwnexDfrN20g</id>
    <link href="https://mp.weixin.qq.com/s/TJwT56jketvwnexDfrN20g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本6分的SCI，明年或超8+，平均两个月可接受，年发文量超6200篇</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/MGjr5RyErJtbZ9msqBqZSw</id>
    <link href="https://mp.weixin.qq.com/s/MGjr5RyErJtbZ9msqBqZSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这两本“高自引黑名单”的SCI期刊，影响因子失而复得：科睿唯安将其撤下“高自引黑名单”</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/uLsKisaAoUQtZIM43ApKmw</id>
    <link href="https://mp.weixin.qq.com/s/uLsKisaAoUQtZIM43ApKmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本Science子刊，年发文上千篇，今年影响因子13+</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/0V2kMZ-xvRgUQZJAv8ox6A</id>
    <link href="https://mp.weixin.qq.com/s/0V2kMZ-xvRgUQZJAv8ox6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本国产4分+的SCI，Letter和Research Highlight文章免发表费</title>
    <updated>2020-11-05T22:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/BQWN6h0lzFSAN8hWRIfYWA</id>
    <link href="https://mp.weixin.qq.com/s/BQWN6h0lzFSAN8hWRIfYWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>教育部：评价学术论文，代表作中必须包含一定比例的中国期刊论文 | 采用“中国期刊与国外期刊相结合”的“代表作评价”方法</title>
    <updated>2020-11-04T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/4LQnnMRrvRzp9KAs9XC8IQ</id>
    <link href="https://mp.weixin.qq.com/s/4LQnnMRrvRzp9KAs9XC8IQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官宣！2020年度国家杰青名单正式批准，北京大学14人入选</title>
    <updated>2020-11-04T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/vxydt7BEQdUmcx2s-w7x1Q</id>
    <link href="https://mp.weixin.qq.com/s/vxydt7BEQdUmcx2s-w7x1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>轻松应对“审稿人”，你需要这个神器</title>
    <updated>2020-11-04T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/1LZllg-YeZwUmIvE4gfhMQ</id>
    <link href="https://mp.weixin.qq.com/s/1LZllg-YeZwUmIvE4gfhMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本国产SCI，喜获首个影响因子4.803分</title>
    <updated>2020-11-04T22:25:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/-ispQFUA7v1RRJtVrc4hqg</id>
    <link href="https://mp.weixin.qq.com/s/-ispQFUA7v1RRJtVrc4hqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>